Part 1 | Part 2 | Part 3 |
Notifiable Diseases | ||
Anthrax | Brucellosis | Chlamydial infection (genital) |
Botulism | Campylobacteriosis | Clostridium difficile associated diarrhea |
Cholera | COVID-19 | Creutzfeld-Jacob disease (Classic and New Variant) |
Diphtheria | Cryptosporidiosis | Cytomegalovirus (congenital/neonatal) |
Human influenza caused by a new subtype | Cyclosporiasis | Gonococcal infection |
Measles | Escherichia coli infection (verotoxigenic) | Hepatitis C |
Meningococcal disease (invasive) | Giardiasis | Hepatitis G |
Multisystem inflammatory syndrome in children (MIS-C) | Guillain-Barré syndrome | Hepatitis (other viral) |
Plague | Hantavirus pulmonary syndrome | Herpes (congenital / neonatal) |
Poliomyelitis due to wild-type poliovirus | Haemophilus influenzae infection – all serotypes (invasive) | Human immunodeficiency virus infection / Acquired immunodeficiency syndrome |
Severe acute respiratory syndrome | Hepatitis A | Influenza (laboratory confirmed) |
Smallpox | Hepatitis B | Leprosy |
Yellow fever | Hepatitis E | Leptospirosis |
Viral Haemorrhagic fever | Legionellosis | Lyme borreliosis |
Listeriosis (invasive) | Malaria | |
Mpox | Methicillin-resistant Staphylococcus aureus | |
Mumps | Pneumococcal infection (invasive) | |
Paralytic shellfish poisoning | Psittaccosis | |
Pertussis | Rickettsial infection | |
Q fever | Streptococcus group B infection (neonatal) | |
Rabies | Syphilis (including congenital) | |
Rubella (including congenital) | Tetanus | |
Salmonellosis | Toxoplasmosis | |
Shigellosis | Vancomycin-resistant Enterococci | |
Staphylococcus aureus foodborne intoxications | ||
Streptococcus group A infection (invasive) | ||
Tularemia | ||
Tuberculosis (active) | ||
Typhoid | ||
Varicella | ||
Vibrio species pathogenic to humans (other than Cholera) | ||
West Nile virus infection | ||
Yersinosis | ||
Notifiable Events | ||
Unusual clusters of suspect notifiable disease cases or clusters of unknown aetiology | Exposure to suspected rabid animal | Adverse reaction to a vaccine or other immunizing agent |
Clusters of illness thought to be food- or water-borne or enteric | Unusual illness, defined as follows: patient presenting with symptoms that do not fit any recognizable clinical picture; known aetiology but not expected to occur in New Brunswick; known aetiology that does not behave as expected or clusters presenting with unknown aetiology | Suspect case of an existing or new variant of human or animal prion disease |
Clusters of severe or atypical illness thought to be respiratory-borne | ||
Part 1 | Part 2 | Part 3 |
Notifiable Diseases | ||
Anthrax | Brucellosis | Chlamydial infection (genital) |
Botulism | Campylobacteriosis | Clostridium difficile associated diarrhea |
Cholera | Cryptosporidiosis | Creutzfeld-Jacob disease (Classic and New Variant) |
COVID-19 | Cyclosporiasis | Cytomegalovirus (congenital/neonatal) |
Diphtheria | Escherichia coli infection (verotoxigenic) | Gonococcal infection |
Human influenza caused by a new subtype | Giardiasis | Hepatitis C |
Measles | Guillain-Barré syndrome | Hepatitis G |
Meningococcal disease (invasive) | Hantavirus pulmonary syndrome | Hepatitis (other viral) |
Multisystem inflammatory syndrome in children (MIS-C) | Haemophilus influenzae infection – all serotypes (invasive) | Herpes (congenital / neonatal) |
Plague | Hepatitis A | Human immunodeficiency virus infection / Acquired immunodeficiency syndrome |
Poliomyelitis due to wild-type poliovirus | Hepatitis B | Influenza (laboratory confirmed) |
Severe acute respiratory syndrome | Hepatitis E | Leprosy |
Smallpox | Legionellosis | Leptospirosis |
Yellow fever | Listeriosis (invasive) | Lyme borreliosis |
Viral Haemorrhagic fever | Monkey Pox | Malaria |
Mumps | Methicillin-resistant Staphylococcus aureus | |
Paralytic shellfish poisoning | Pneumococcal infection (invasive) | |
Pertussis | Psittaccosis | |
Q fever | Rickettsial infection | |
Rabies | Streptococcus group B infection (neonatal) | |
Rubella (including congenital) | Syphilis (including congenital) | |
Salmonellosis | Tetanus | |
Shigellosis | Toxoplasmosis | |
Staphylococcus aureus foodborne intoxications | Vancomycin-resistant Enterococci | |
Streptococcus group A infection (invasive) | ||
Tularemia | ||
Tuberculosis (active) | ||
Typhoid | ||
Varicella | ||
Vibrio species pathogenic to humans (other than Cholera) | ||
West Nile virus infection | ||
Yersinosis | ||
Notifiable Events | ||
Unusual clusters of suspect notifiable disease cases or clusters of unknown aetiology | Exposure to suspected rabid animal | Adverse reaction to a vaccine or other immunizing agent |
Clusters of illness thought to be food- or water-borne or enteric | Unusual illness, defined as follows: patient presenting with symptoms that do not fit any recognizable clinical picture; known aetiology but not expected to occur in New Brunswick; known aetiology that does not behave as expected or clusters presenting with unknown aetiology | Suspect case of an existing or new variant of human or animal prion disease |
Clusters of severe or atypical illness thought to be respiratory-borne | ||
Part 1 | Part 2 | Part 3 |
Notifiable Diseases | ||
Anthrax | Brucellosis | Chlamydial infection (genital) |
Botulism | Campylobacteriosis | Clostridium difficile associated diarrhea |
Cholera | Cryptosporidiosis | Creutzfeld-Jacob disease (Classic and New Variant) |
COVID-19 | Cyclosporiasis | Cytomegalovirus (congenital/neonatal) |
Diphtheria | Escherichia coli infection (verotoxigenic) | Gonococcal infection |
Human influenza caused by a new subtype | Giardiasis | Hepatitis C |
Measles | Guillain-Barré syndrome | Hepatitis G |
Meningococcal disease (invasive) | Hantavirus pulmonary syndrome | Hepatitis (other viral) |
Multisystem inflammatory syndrome in children (MIS-C) | Haemophilus influenzae infection – all serotypes (invasive) | Herpes (congenital / neonatal) |
Plague | Hepatitis A | Human immunodeficiency virus infection / Acquired immunodeficiency syndrome |
Poliomyelitis due to wild-type poliovirus | Hepatitis B | Influenza (laboratory confirmed) |
Severe acute respiratory syndrome | Hepatitis E | Leprosy |
Smallpox | Legionellosis | Leptospirosis |
Yellow fever | Listeriosis (invasive) | Lyme borreliosis |
Viral Haemorrhagic fever | Mumps | Malaria |
Paralytic shellfish poisoning | Methicillin-resistant Staphylococcus aureus | |
Pertussis | Pneumococcal infection (invasive) | |
Q fever | Psittaccosis | |
Rabies | Rickettsial infection | |
Rubella (including congenital) | Streptococcus group B infection (neonatal) | |
Salmonellosis | Syphilis (including congenital) | |
Shigellosis | Tetanus | |
Staphylococcus aureus foodborne intoxications | Toxoplasmosis | |
Streptococcus group A infection (invasive) | Vancomycin-resistant Enterococci | |
Tularemia | ||
Tuberculosis (active) | ||
Typhoid | ||
Varicella | ||
Vibrio species pathogenic to humans (other than Cholera) | ||
West Nile virus infection | ||
Yersinosis | ||
Notifiable Events | ||
Unusual clusters of suspect notifiable disease cases or clusters of unknown aetiology | Exposure to suspected rabid animal | Adverse reaction to a vaccine or other immunizing agent |
Clusters of illness thought to be food- or water-borne or enteric | Unusual illness, defined as follows: patient presenting with symptoms that do not fit any recognizable clinical picture; known aetiology but not expected to occur in New Brunswick; known aetiology that does not behave as expected or clusters presenting with unknown aetiology | Suspect case of an existing or new variant of human or animal prion disease |
Clusters of severe or atypical illness thought to be respiratory-borne | ||
Part 1 | Part 2 | Part 3 |
Notifiable Diseases | ||
Anthrax | Brucellosis | Chlamydial infection (genital) |
Botulism | Campylobacteriosis | Clostridium difficile associated diarrhea |
Cholera | Cryptosporidiosis | Creutzfeld-Jacob disease (Classic and New Variant) |
COVID-19 | Cyclosporiasis | Cytomegalovirus (congenital/neonatal) |
Diphtheria | Escherichia coli infection (verotoxigenic) | Gonococcal infection |
Human influenza caused by a new subtype | Giardiasis | Hepatitis C |
Measles | Guillain-Barré syndrome | Hepatitis G |
Meningococcal disease (invasive) | Hantavirus pulmonary syndrome | Hepatitis (other viral) |
Multisystem inflammatory syndrome in children (MIS-C) | Haemophilus influenzae infection – all serotypes (invasive) | Herpes (congenital / neonatal) |
Plague | Hepatitis A | Human immunodeficiency virus infection / Acquired immunodeficiency syndrome |
Poliomyelitis due to wild-type poliovirus | Hepatitis B | Influenza (laboratory confirmed) |
Severe acute respiratory syndrome | Hepatitis E | Leprosy |
Smallpox | Legionellosis | Leptospirosis |
Yellow fever | Listeriosis (invasive) | Lyme borreliosis |
Viral Haemorrhagic fever | Mumps | Malaria |
Paralytic shellfish poisoning | Methicillin-resistant Staphylococcus aureus | |
Pertussis | Pneumococcal infection (invasive) | |
Q fever | Psittaccosis | |
Rabies | Rickettsial infection | |
Rubella (including congenital) | Streptococcus group B infection (neonatal) | |
Salmonellosis | Syphilis (including congenital) | |
Shigellosis | Tetanus | |
Staphylococcus aureus foodborne intoxications | Toxoplasmosis | |
Streptococcus group A infection (invasive) | Vancomycin-resistant Enterococci | |
Tularemia | ||
Tuberculosis (active) | ||
Typhoid | ||
Varicella | ||
Vibrio species pathogenic to humans (other than Cholera) | ||
West Nile virus infection | ||
Yersinosis | ||
Notifiable Events | ||
Unusual clusters of suspect notifiable disease cases or clusters of unknown aetiology | Exposure to suspected rabid animal | Adverse reaction to a vaccine or other immunizing agent |
Clusters of illness thought to be food- or water-borne or enteric | Unusual illness, defined as follows: patient presenting with symptoms that do not fit any recognizable clinical picture; known aetiology but not expected to occur in New Brunswick; known aetiology that does not behave as expected or clusters presenting with unknown aetiology | |
Clusters of severe or atypical illness thought to be respiratory-borne | ||
Part 1 | Part 2 | Part 3 |
Notifiable Diseases | ||
Anthrax | Brucellosis | Chlamydial infection (genital) |
Botulism | Campylobacteriosis | Clostridium difficile associated diarrhea |
Cholera | Cryptosporidiosis | Creutzfeld-Jacob disease (Classic and New Variant) |
COVID-19 | Cyclosporiasis | Cytomegalovirus (congenital/neonatal) |
Diphtheria | Escherichia coli infection (verotoxigenic) | Gonococcal infection |
Human influenza caused by a new subtype | Giardiasis | Hepatitis C |
Measles | Guillain-Barré syndrome | Hepatitis G |
Meningococcal disease (invasive) | Hantavirus pulmonary syndrome | Hepatitis (other viral) |
Plague | Haemophilus influenzae infection – all serotypes (invasive) | Herpes (congenital / neonatal) |
Poliomyelitis due to wild-type poliovirus | Hepatitis A | Human immunodeficiency virus infection / Acquired immunodeficiency syndrome |
Severe acute respiratory syndrome | Hepatitis B | Influenza (laboratory confirmed) |
Smallpox | Hepatitis E | Leprosy |
Yellow fever | Legionellosis | Leptospirosis |
Viral Haemorrhagic fever | Listeriosis (invasive) | Lyme borreliosis |
Mumps | Malaria | |
Paralytic shellfish poisoning | Methicillin-resistant Staphylococcus aureus | |
Pertussis | Pneumococcal infection (invasive) | |
Q fever | Psittaccosis | |
Rabies | Rickettsial infection | |
Rubella (including congenital) | Streptococcus group B infection (neonatal) | |
Salmonellosis | Syphilis (including congenital) | |
Shigellosis | Tetanus | |
Staphylococcus aureus foodborne intoxications | Toxoplasmosis | |
Streptococcus group A infection (invasive) | Vancomycin-resistant Enterococci | |
Tularemia | ||
Tuberculosis (active) | ||
Typhoid | ||
Varicella | ||
Vibrio species pathogenic to humans (other than Cholera) | ||
West Nile virus infection | ||
Yersinosis | ||
Notifiable Events | ||
Unusual clusters of suspect notifiable disease cases or clusters of unknown aetiology | Exposure to suspected rabid animal | Adverse reaction to a vaccine or other immunizing agent |
Clusters of illness thought to be food- or water-borne or enteric | Unusual illness, defined as follows: patient presenting with symptoms that do not fit any recognizable clinical picture; known aetiology but not expected to occur in New Brunswick; known aetiology that does not behave as expected or clusters presenting with unknown aetiology | |
Clusters of severe or atypical illness thought to be respiratory-borne | ||
Part 1 | Part 2 | Part 3 |
Notifiable Diseases | ||
Anthrax | Brucellosis | Chlamydial infection (genital) |
Botulism | Campylobacteriosis | Clostridium difficile associated diarrhea |
Cholera | Cryptosporidiosis | Creutzfeld-Jacob disease (Classic and New Variant) |
Diphtheria | Cyclosporiasis | Cytomegalovirus (congenital/neonatal) |
Human influenza caused by a new subtype | Escherichia coli infection (verotoxigenic) | Gonococcal infection |
Measles | Giardiasis | Hepatitis C |
Meningococcal disease (invasive) | Guillain-Barré syndrome | Hepatitis G |
Plague | Hantavirus pulmonary syndrome | Hepatitis (other viral) |
Poliomyelitis due to wild-type poliovirus | Haemophilus influenzae infection – all serotypes (invasive) | Herpes (congenital / neonatal) |
Severe acute respiratory syndrome | Hepatitis A | Human immunodeficiency virus infection / Acquired immunodeficiency syndrome |
Smallpox | Hepatitis B | Influenza (laboratory confirmed) |
Yellow fever | Hepatitis E | Leprosy |
Viral Haemorrhagic fever | Legionellosis | Leptospirosis |
Listeriosis (invasive) | Lyme borreliosis | |
Mumps | Malaria | |
Paralytic shellfish poisoning | Methicillin-resistant Staphylococcus aureus | |
Pertussis | Pneumococcal infection (invasive) | |
Q fever | Psittaccosis | |
Rabies | Rickettsial infection | |
Rubella (including congenital) | Streptococcus group B infection (neonatal) | |
Salmonellosis | Syphilis (including congenital) | |
Shigellosis | Tetanus | |
Staphylococcus aureus foodborne intoxications | Toxoplasmosis | |
Streptococcus group A infection (invasive) | Vancomycin-resistant Enterococci | |
Tularemia | ||
Tuberculosis (active) | ||
Typhoid | ||
Varicella | ||
Vibrio species pathogenic to humans (other than Cholera) | ||
West Nile virus infection | ||
Yersinosis | ||
Notifiable Events | ||
Unusual clusters of suspect notifiable disease cases or clusters of unknown aetiology | Exposure to suspected rabid animal | Adverse reaction to a vaccine or other immunizing agent |
Clusters of illness thought to be food- or water-borne or enteric | Unusual illness, defined as follows: patient presenting with symptoms that do not fit any recognizable clinical picture; known aetiology but not expected to occur in New Brunswick; known aetiology that does not behave as expected or clusters presenting with unknown aetiology | |
Clusters of severe or atypical illness thought to be respiratory-borne | ||
Part 1 | Part 2 | Part 3 |
Communicable Diseases | ||
Anthrax | Brucellosis | Chlamydial infection (genital) |
Cholera | Campylobacteriosis | Clostridium difficile associated diarrhea |
Diphtheria | Cryptosporidiosis | Creutzfeld-Jacob disease- Classic and New Variant |
Hemorrhagic fever diseases | Cyclosporiasis | Cytomegalovirus (neonatal/congenital) |
Influenza caused by a new subtype | Escherichia coli (pathogenic) | Gonococcal infection |
Measles | Giardiasis | Hepatitis C |
Plague - pneumonic | Hepatitis G | |
Poliomyelitis | Hantavirus pulmonary syndrome | Hepatitis - other viral |
Severe acute respiratory syndrome | Haemophilus influenzae (invasive) - type B and non-B | Herpes (congenital) |
Smallpox | Hepatitis A | Human immunodeficiency virus/Acquired immunodeficiency syndrome |
Yellow fever | Hepatitis B | Influenza (laboratory confirmed) |
Hepatitis E | Leprosy | |
Legionellosis | Leptospirosis | |
Listeriosis (invasive) | Lyme borreliosis | |
Meningococcal (invasive) disease | Malaria | |
Mumps | Pneumococcal disease (invasive) | |
Pertussis | Psittaccosis | |
Plague - bubonic | Rickettsial infection | |
Q fever | Streptococcus B (neonatal) | |
Rabies | Syphilis | |
Rubella | ||
Salmonellosis | ||
Shigellosis - bacillary dysentry | ||
Staphylococcus aureus intoxications | ||
Streptococcus A- beta-hemolytic (invasive) | ||
Tularemia | ||
Tuberculosis (active) | ||
Typhoid | ||
Varicella | ||
Vibrio species | ||
West Nile virus infection | ||
Yersinosis | ||
Notifiable Diseases | ||
Botulism | Guillain-Barré syndrome | Tetanus |
Paralytic shellfish poisoning | ||
Reportable Events | ||
Clusters of illness thought to be food or water borne | Exposure to suspected rabid animal | Adverse reaction to a vaccine or other immunizing agent |
Clusters of severe or atypical illness thought to be respiratory borne | Unusual illness, defined as follows: patient presenting with symptoms that do not fit any recognizable clinical picture; known aetiology but not expected to occur in New Brunswick; known aetiology that does not behave as expected or clusters presenting with unknown aetiology | |